AroCell and Corgenix establish the measurement of Thymidine Kinase 1 using AroCell TK 210 ELISA in a CLIA-lab in the USA
15 avr. 2019 02h00 HE
|
AroCell AB
AroCell AB (AROC NASDAQ Stockholm) announce today, in collaboration with Corgenix (Corgenix Inc., Colorado USA) that the AroCell TK 210 ELISA kit has been validated and approved for Thymidine Kinase 1...
AroCell årsredovisning för 2018 publicerad
12 avr. 2019 05h30 HE
|
AroCell AB
AroCell meddelar idag att årsredovisningen för 2018 nu finns tillgänglig på bolagets hemsida www.arocell.com. Årsredovisningen går hitta på följande länk: arocell.com/årsredovisning-2018 Denna...
AroCell´s 2018 Annual Report published
12 avr. 2019 05h30 HE
|
AroCell AB
AroCell today announces that the Annual Report for 2018 is now available on the company’s website: www.arocell.com. The Annual report is available on the following link:...
Rättad version av pressmeddelande publicerad 20 mars 2019: Ny vetenskaplig publikation från AroCell på TK 210 ELISA i prostatacancer
20 mars 2019 05h27 HE
|
AroCell AB
Rättelsen består av att vi har lagt till en länk till artikeln. Syftet med studien var att undersöka det diagnostiska värdet av AroCell TK 210 ELISA tillsammans med fri-PSA, Pro PSA och PHI för att...
CORRECTED VERSION of March 20, 2019 Press Release: New scientific publication from AroCell on TK 210 ELISA in prostate cancer
20 mars 2019 05h27 HE
|
AroCell AB
In the corrected version of the press release we have added a link to the article. The aim of the study was to investigate the diagnostic value of the AroCell TK 210 ELISA together with free PSA,...
Ett nytt studieresultat med AroCell TK 210 ELISA vid prostatacancer har accepterats för publicering
25 févr. 2019 02h30 HE
|
AroCell AB
Studien med titeln “The combination of AroCell TK 210 ELISA with Prostate Health Index (PHI) or PSA density can improve the ability to differentiate prostate cancer from non-cancerous conditions”,...
New study results with AroCell TK 210 ELISA in prostate cancer has been accepted for publication
25 févr. 2019 02h30 HE
|
AroCell AB
The study with the title “The combination of AroCell TK 210 ELISA with Prostate Health Index (PHI) or PSA density can improve the ability to differentiate prostate cancer from non-cancerous...
AroCell AB (publ) Bokslutskommuniké 2018
21 févr. 2019 02h30 HE
|
AroCell AB
VD-ORD ”2018 har varit ett spännande år för AroCell med flera stora händelser. I april tecknade AroCell ett globalt icke exklusivt licensavtal med F. Hoffmann-La Roche Ltd (Roche). Roche är...
AroCell AB (publ) Year-End Report 2018
21 févr. 2019 02h30 HE
|
AroCell AB
Word from the CEO ”2018 has been an exciting year for AroCell with several major events. In April, AroCell signed a global non-exclusive license agreement with F. Hoffmann-La Roche Ltd (Roche). Roche...
AroCell launches new website
01 févr. 2019 07h32 HE
|
AroCell AB
Today AroCell is launching its new website. The goal with the new website is to facilitate for our customers, business partner, and investors to find relevant information about AroCell. The website...